Ignite Creation Date:
2024-05-05 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00762086
Status:
COMPLETED
Last Update Posted:
2012-08-31
First Post:
2008-09-28
Brief Title:
Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease PAD Stage II
Sponsor:
Mego Afek Ltd
Organization:
Mego Afek Ltd
Study Overview
Official Title:
A Prospective Randomized Multi-center Clinical Trial to Evaluate the Efficacy and Safety of a New Intermittent Pneumatic Compression Device on Initial Claudication Distance in Patients With Peripheral Arterial Disease Stage II
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of new intermittent pneumatic compression device on initial claudication distance in patients with Peripheral Arterial Disease stage II
Detailed Description:
Patients with Peripheral Arterial Disease PAD suffer from symptoms such as intermittent claudication limb and foot pain and tissue lesions which are difficult to treat In recent years there have been reports demonstrating reduction of these symptoms by use of compressible sleeve devices
This clinical study aims at demonstrating the safety and effectiveness of this device in treating PAD symptoms
This clinical study aims at demonstrating the safety and effectiveness of this device in treating PAD symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None